Patents by Inventor Oliver Graner

Oliver Graner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS
    Publication number: 20180161280
    Abstract: The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament.
    Type: Application
    Filed: February 12, 2018
    Publication date: June 14, 2018
    Inventors: Anke DIEDERICH, Hans-Ulrich KUNZLER, Oliver GRANER
  • Solid Pharmaceutical Composition Comprising PI3K-Inhibitor
    Publication number: 20170209455
    Abstract: The application relates to solid pharmaceutical compositions suitable for oral administration, processes for their production and uses of the pharmaceutical compositions.
    Type: Application
    Filed: July 24, 2015
    Publication date: July 27, 2017
    Applicant: Novartis AG
    Inventors: Dipen Desai, Bruno Galli, Rakesh Patel, Manuel Vincente Sanchez-Felix, Frank Hans Seiler, Navnit H. Shah, Daya D. Verma, Toni Widmer, Stefanie Meyer, Raman Iyer, Severine Serreau, Simone Grandolini, Oliver Graner
  • Pharmaceutical Compositions Comprising Everolimus
    Publication number: 20160045441
    Abstract: The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxyethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament.
    Type: Application
    Filed: March 19, 2014
    Publication date: February 18, 2016
    Applicant: Novartis AG
    Inventors: Anke DIEDERICH, Hans-Ulrich KUNZLER, Oliver Graner